• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Dexcom CFO to expand into COO role

Dexcom CFO to expand into COO role

September 15, 2026 By Conor Hale

This is a LinkedIn portrait photo of Dexcom CFO and COO Jereme Sylvain.
Dexcom CFO Jereme Sylvain is now also COO. [Image from Sylvain’s LinkedIn profile]
Dexcom‘s (Nasdaq:DXCM) C-suite is seeing another of its members take on multiple roles. Its chief financial officer will now also serve as chief operating officer.

Jereme Sylvain joined the diabetes tech company in 2018, and has been its CFO and executive VP since 2021. His new COO hat will add oversight of Dexcom’s global operations and quality teams, as the company looks ahead to the development of its next-gen G8 continuous glucose monitor and broadening the reach of its over-the-counter Stelo wearable.

Dexcom’s previous COO, Jake Leach, had claimed the title of president last year as well, before formally taking the helm of the company as CEO in January, following the departure of long-time chief Kevin Sayer.

Get more details on Drug Delivery Business News.

Filed Under: Business/Financial News, Diabetes, Wall Street Beat Tagged With: Dexcom, diabetes, Personnel Moves

More recent news

  • Dexcom CFO to expand into COO role
  • Powerful Medical announces FDA De Novo nod for AI ECG and other extra medtech news
  • XCath Robotics receives FDA breakthrough nod for Iris system
  • Intuitive gets expanded indication for da Vinci SP in Europe
  • Beta Bionics insulin patch pump scores FDA clearance

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy